Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Cardlytics Inc (CDLX).
Cardlytics, Inc. has successfully completed its “at the market” offering program, having issued and sold shares totaling $50.0 million. On March 18, 2024, the company offloaded 3,907,600 shares at an average price of $12.80 each, wrapping up the sales initiative in collaboration with Evercore Group L.L.C., BofA Securities, Inc., and Cantor Fitzgerald & Co. This strategic move has bolstered Cardlytics’ financial position, offering a fresh infusion of capital to the tech-savvy investment community.
See more data about CDLX stock on TipRanks’ Stock Analysis page.